FDA 授予 ATEBRIOZ（Zilurgisertib）罕见儿科疾病产品优先审评券
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ATEBRIOZ (Zilurgisertib)
FDA 就罕见儿科疾病产品 ATEBRIOZ（Zilurgisertib）签发优先审评券。该券可用于加速后续药物申请的审评。
Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. Please visit FederalRegister.gov API documentation or eCFR.gov API documentation to learn more about how to access the API.
Your request has been flagged as potentially automated. If you are human user receiving this message, please complete the CAPTCHA (bot test) below and click "Request Access". You may occassionally be asked to complete the CAPTCHA again, this is normal and part of our security measures.
An official website of the United States government.
If you experiencing issues with the CAPTCHA or want to request a wider IP range, you can use the "Site Help" button found in the lower, right of this page to make a request.
来源：Federal Register · FDA · federalregister.gov